利用全基因组寡核苷酸筛选大肠癌差异表达基因

南方医科大学学报 ›› 2005, Vol. 25 ›› Issue (09): 1109-1113.

利用全基因组寡核苷酸筛选大肠癌差异表达基因

许红民¹, 王强², 白雪娟², 钟定荣³, 曹秀堂⁴, 张金萍², 丁彦青¹, 姚开泰¹

1. 南方医科大学病理解剖教研室肿瘤研究所, 广东, 广州, 510515;
2. 解放军总医院第二附属医院, 北京, 100091;
3. 解放军总医院病理科, 北京, 100853;
4. 解放军总医院医疗质量管理研究科, 北京, 100853

出版日期:2005-09-20 发布日期:2005-09-20
基金资助:
收稿日期:2005-6-28。
基金项目:国家“973”项目(2001CB510208);军队“十五”医学科研基金重点项目(04Z041)
作者简介:许红民(1957- ),女,2004年毕业于第一军医大学,博士,现为解放军总医院第二附属医院副院长,主任医师,教授,享受政府特殊津贴,电话:010-66775199,E-mail:xuhm301@yahoo.com.cn.

Screening of differentially expressed genes in colorectal cancer using human whole genomic oligonucleotide microarrays

XU Hong-min¹, WANG Qiang², BAI Xue-juan², ZHONG Ding-rong³, CAO Xiu-tang⁴, ZHANG Jin-ping², Ding Yan-qing¹, YAO Kai-tai¹

1. 南方医科大学病理解剖教研室肿瘤研究所, 广东, 广州, 510515;
2. 解放军总医院第二附属医院, 北京, 100091;
3. 解放军总医院病理科, 北京, 100853;
4. 解放军总医院医疗质量管理研究科, 北京, 100853

Online:2005-09-20 Published:2005-09-20

摘要/Abstract

摘要： 目的筛查人大肠癌组织与相应正常大肠粘膜差异表达基因。方法应用美国AffymetrixHG-U133寡核苷酸芯片(代表迄今所知的32264个人类全基因,包括19308个已知的人类基因和12956个EST簇)检测9例大肠癌组织及相应正常大肠粘膜基因表达谱,并以实时荧光定量PCR技术对基因芯片检测结果进行验证;综合运用交集补集、秩和检验及t检验比较两组表达谱数据。结果获得大肠癌组织与正常大肠粘膜组织差异表达基因和ESTs3125个(包括肿瘤上调基因ESTs974个、下调基因ESTs2151个);大肠癌组织表达而相应正常粘膜不表达的ESTs245个;大肠癌组织不表达而正常粘膜表达的ESTs162个;最重要的大肠癌差异表达基因ESTs17个。本研究所筛得之大肠癌差异表达基因80.1%未见报道。结论综合运用交集补集分析、t检验、秩和检验对基因谱数据进行挖掘的策略,可为寻找大肠癌分子标记物和从整体上探讨大肠癌发生的分子机制奠定基础。

Abstract: Objective To screen the differentially expressed genes in human colorectal cancer (CRC) tissue. Methods Affymetrix oligonucleotide microarrays HG-U133 representing 32 264 human genes including 19 308 known genes and 12 956 expressed sequence tags (ESTs) were used to detect the gene expressions of CRC tissue paired with normal mucosa tissue. The microarray findings were confirmed by real-time quantitative reverse transcriptase-polymerase chain reaction (FQ-PCR). The gene expression profiles were analyzed by intersection and complement, rank sum test and t test. Results Totally 3 125 genes and ESTs expressed differentially were detected in normal and cancer tissues, consisting of 974 up-regulated and 2 151 down-regulated genes with 247 ESTs present in CRC tissue and absent in normal mucosa and 162 ESTs absent in CRC tissue but present in normal mucosa. A percent of 80.1% of the differentially expressed genes were not reported in the literatures. Conclusion The strategy of data mining provides a foundation for filtering molecular markers and interpreting molecular carcinogenesis of CRC.

中图分类号:

R735.34

许红民¹, 王强², 白雪娟², 钟定荣³, 曹秀堂⁴, 张金萍², 丁彦青¹, 姚开泰¹. 利用全基因组寡核苷酸筛选大肠癌差异表达基因[J]. 南方医科大学学报, 2005, 25(09): 1109-1113.

XU Hong-min¹, WANG Qiang², BAI Xue-juan², ZHONG Ding-rong³, CAO Xiu-tang⁴, ZHANG Jin-ping², Ding Yan-qing¹, YAO Kai-tai¹. Screening of differentially expressed genes in colorectal cancer using human whole genomic oligonucleotide microarrays[J]. Journal of Southern Medical University, 2005, 25(09): 1109-1113.

参考文献

[1] Birkenkamp-Demtroder K, Christensen LL, Olesen SH, et al. Gene expression in colorectal cancer [J]. Cancer Res, 2002, 4352-63.
[2] Kwon HC, Kim SH, Rob MS. Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer [J]. Dis Colon Rectum, 2004, 47(2):141-52.
[3] 黄仲曦,丁彦青,姚开泰.用文献轮廓挖掘大肠癌转移芯片表达谱[J].第一军医大学学报,2003,23(11):1195-7.Huang ZX, Ding YQ, Yao KT. Mining microarray gene expression data of metastatic colorectal cancer by literature profiling [J].J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2003, 23(11):1195-7.
[4] 孙青,丁彦青,高雪芹.肿瘤转移相关基因cDNA芯片的制备与应用[J].第一军医大学学报,2002,22(12):1070-6.Sun Q, Ding YQ, Gao XQ. Development and application of cDNA microarray of tumor metastasis-associated genes [J].J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(12):1070-6.
[5] 谷志远.现代医学分子生物学[M].北京:人民军医出版社,2000.238-9.
[6] Huang Q, Liu D, Majewski P, et al. The plasticity of dendritic cell responses to pathogens and their components[J]. Science, 2002, 26(294):870-875.
[7] Imanishi T, Itoh T, Suzuki Y, et al. Integrative annotation of 21,037 human genes validated by full-length cDNA clones [J]. Plos Biol,2004, 2(6):0001-20.
[8] Zhao LP, Prentice R, Breeden L. Statistical modeling of large microarray data sets to identify stimulus-response profiles [J]. Proc Natl Acad Sci USA, 2001, 98(10):5631-6.
[9] Shou J, Soriano R, Hayward SW, et al. Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression [J]. Proc Natl Acad Sci USA, 2002, 99(5):2830-5.
[10] Wood JR, Nelson VL, ho C, et al. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate pCOS genes defined by microarray analysis [J].J Biol Chem, 2003,278(29):26380-90.
[11] LaTulippe E, Satagopan J, Smith A. Comprehensive gene expession analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease [J]. Cancer Res, 2002, 62:4499-506.
[12] Tackels-Home D, Goodman MD. Identification of differential expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling [J]. Cancer, 2001, 92(15):395-405.
[13] Jin G, Hu XG, Mao YM. Analysis of gene expression patterns in pancreatic cancer by cDNA microarray[J]. Acad J Sec Mil Med Univ. 2000, 21(9):819-22.
[14] Cousins R, Blanchard RK, Green CL, et al. A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells[J]. Proc Natl Acad Sci USA, 2003,100(12):6952-7.